Chemical giant Chemours delays quarterly earnings release, internal review underway

Chemours Co.’s stock dropped more than 4% in the extended session Tuesday after the chemicals company delayed its quarterly financial results, saying it “needs additional time.”

Previous post Arm’s stock suffers its worst day on record as AI euphoria cools
Next post Jeff Bezos unloads another $2 billion of Amazon stock. He’s sold $4 billion this month.